中宠股份收监管措施 实控人方减持中A股4募资共20亿

Core Viewpoint - Zhongchong Co., Ltd. (002891.SZ) has received an administrative regulatory measure from the Shandong Securities Regulatory Bureau due to a failure to disclose a significant change in shareholding following a convertible bond conversion, which resulted in a decrease in the holding percentage of its controlling shareholder from 26.08% to 25.94% [1] Group 1: Regulatory Actions - The Shandong Securities Regulatory Bureau issued a decision requiring Zhongchong to correct its actions and engage in regulatory discussions due to non-compliance with disclosure regulations [1] - Zhongchong is advised to enhance its understanding of securities laws and improve its operational standards and information disclosure quality to prevent future violations [1] Group 2: Shareholding Changes - On April 29, 2025, the controlling shareholder's stake decreased due to the conversion of convertible bonds, which triggered a requirement for disclosure that was not fulfilled by Zhongchong [1] - The controlling shareholder, Yantai Zhongxing Biotechnology Co., Ltd., and its action in concert, Shanghai Tongyi Investment Management Co., Ltd., did not announce the change in shareholding as required [1] Group 3: Share Reduction Plans - On July 16, 2025, Zhongchong announced a share reduction plan by its controlling shareholder's action in concert, which involves a maximum reduction of 4.56 million shares (1.50% of total shares) within a specified period [2] - The share reduction is planned to occur through block trades and/or centralized bidding from August 7 to November 6, 2025 [2] Group 4: Fundraising Activities - Zhongchong has conducted multiple fundraising activities, including the issuance of convertible bonds and non-public offerings, with total fundraising amounting to 2 billion yuan across four instances [6] - The company has consistently engaged in fundraising through various financial instruments, demonstrating its active capital management strategy [3][4][5]